CClinicalTrials.gg
CompletedNCT07736014Updated Jul 30, 2026

Adapted Physical Activity and Tango-Based Therapy for Parkinson's Disease: A Pilot Study

An interventional study of Riabilitango® Tango-based program and Motor Reconditioning in Parkinson's Disease (PD), sponsored by University of Foggia. Completed at 1 site in Italy. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by University of Foggia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

The purpose of this clinical research is to evaluate the effectiveness of a structured Tango-based (Riabilitango®) therapy compared to a conventional Motor Reconditioning program and a Control group in individuals diagnosed with Parkinson's Disease. The study assesses changes in motor performance, balance, gait kinematics, functional strenght, and health-related quality of life over a 3-month intervention period and a 3-month post-intervention follow-up.

Read the detailed description

Parkinson's disease is characterized by motor deficits affecting gait, postural control, and dynamic balance. This study compares two exercise-based rehabilitation approaches against a control group:

Riabilitango® (Tango Therapy): Supervised group sessions (2 times/week, 60 minutes/session for 3 months) focusing on balance, trunk mobility, rhythm-synchronised walking, and adapted Argentine tango figures.

Motor Reconditioning: Supervised small-group sessions (2 times/week, 60 minutes/session for 3 months) including cycling warm-up, progressive treadmill walking (60-70% max heart rate), upper/lower-limb functional training, and stretching exercises.

Control Group: Follows usual care without participating in the structured rehabilitation interventions during the study period.

Comprehensive clinical, functional, and biomechanical evaluations are conducted at baseline, monthly during the 3-month intervention period, and at a 3-month post-intervention follow-up (6 months total observation period).

02

Conditions studied

  • Parkinson's Disease (PD)

Browse trials for

03

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Confirmed clinical diagnosis of idiopathic Parkinson's Disease.
  • Mild to moderate disease severity (Hoehn and Yahr stage I-III).
  • Ability to walk independently (with or without assistive devices).
  • Stable antiparkinsonian pharmacological treatment for at least 4 weeks prior to enrollment.
  • Ability to understand study procedures and willingness to sign the Informed Consent document.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment or dementia preventing comprehension of instructions or active participation.
  • Severe cardiovascular, respiratory, orthopedic, or other neurological conditions that impair safe exercise participation or gait evaluation.
  • Surgical interventions that directly affect mobility or dynamic balance (e.g., Deep Brain Stimulation or recent major orthopedic surgery).
  • Concurrent participation in other physical rehabilitation programs or clinical trials during the study period.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Tango-based program (Riabilitango®)

    Participants receive a structured tango-based rehabilitation programme (Riabilitango®) delivered by a qualified tango instructor. The intervention lasts 3 months, attending 2 supervised 60-minute sessions per week in group format (approx. 10 participants). The sessions focus on ankle/foot warm-up, balance and stick exercises for trunk mobility, rhythm-synchronised walking, and adapted Argentine tango figures.

    Other: Riabilitango® Tango-based program

  • Active comparator
    Motor Reconditioning

    Participants undergo a conventional motor reconditioning programme supervised by a qualified kinesiologist. The intervention lasts 3 months, with 2 supervised 60-minute sessions per week in small groups (2-3 participants). The program includes stationary cycling, progressive treadmill walking, functional strength training, postural transitions, and stretching exercises.

    Other: Motor Reconditioning

  • No intervention
    Control group

    Participants assigned to the control group do not participate in any structured exercise or rehabilitation intervention during the 3-month study period. They maintain their routine medical care and daily habits.

Interventions

  • OtherRiabilitango® Tango-based program

    Supervised group tango therapy incorporating warm-up exercises, trunk mobility routines, rhythm-synchronised walking, partner activities, and progressive adapted tango patterns tailored for individuals with Parkinson's disease.

  • OtherMotor Reconditioning

    Supervised motor reconditioning including a cycling warm-up, progressive treadmill walking at 60-70% of age-predicted maximal heart rate, functional upper-limb exercises, and stretching routines.

05

What researchers measure

Primary outcomes

  1. Change in Unified Parkinson's Disease Rating Scale (UPDRS) Part III Motor Examination Score

    The UPDRS Part III evaluates motor function in individuals with Parkinson's disease, including speech, facial expression, tremor, rigidity, finger taps, hand movements, gait, posture, and bradykinesia. Scores range from 0 to 56, with higher scores indicating greater motor impairment.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

Secondary outcomes

  1. Timed Up and Go (TUG) Test Time

    Time in seconds taken by the participant to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. Shorter completion times indicate better functional mobility.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  2. Six-Minute Walk Test (6MWT) Distance

    Total distance walked in meters during 6 minutes. Higher values indicate better functional walking endurance.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  3. Handgrip Strength

    Maximum isometric handgrip force measured using a digital dynamometer. Higher values indicate greater upper-limb muscle strength.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  4. Sit-and-Reach Test Distance

    Lower back and hamstring flexibility evaluated via the Sit-and-Reach test. Higher values indicate better flexibility.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  5. Back Scratch Test Distance

    Shoulder and upper body flexibility evaluated via the Back Scratch test. Higher values (or less negative values) indicate better shoulder flexibility.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  6. Gait Speed

    Walking speed evaluated during treadmill locomotion using the Walker View system. Higher values indicate better walking capacity.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  7. Step Length

    Average step length during treadmill locomotion evaluated using the Walker View system. Higher values indicate longer step length.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  8. Vertical Displacement During Gait

    Vertical movement of the body center of mass during gait, evaluated using the Walker View treadmill system.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  9. Postural Alignment During Gait

    Trunk alignment and posture during treadmill walking evaluated using the Walker View system.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  10. Postural Sway Area

    Total ellipse area of postural sway during quiet standing with eyes open and closed, evaluated using the ProKin stabilometric platform. Lower values indicate better postural stability.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  11. Center of Pressure Displacement Length

    Total trajectory length of the Center of Pressure (CoP) evaluated using the ProKin stabilometric platform under eyes open and closed conditions. Lower values indicate better static postural control.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  12. Pelvic Proprioceptive Balance

    Dynamic pelvic proprioceptive control evaluated using the ProKin dynamic platform. Higher percentage scores indicate better proprioceptive stability.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  13. Supine Postural Asymmetries

    Evaluation of body alignment asymmetries in a supine position using the Postural Bench system. Lower angular values indicate greater postural symmetry.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  14. 39-Item Parkinson's Disease Questionnaire (PDQ-39) Summary Index

    Assessed using the 39-Item Parkinson's Disease Questionnaire (PDQ-39). The Summary Index ranges from 0% to 100%, where lower percentage scores represent better quality of life and lower disease burden.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  15. 36-Item Short Form Health Survey (SF-36) Total Score

    Assessed using the 36-Item Short Form Health Survey (SF-36). Total scores range from 0 to 100, where higher scores indicate better perceived health status and overall quality of life.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

  16. Zung Self-Rating Depression Scale Score

    Assessed using the Zung Self-Rating Depression Scale. Total raw scores range from 20 to 80, where higher scores indicate greater severity of depressive symptoms.

    Time frame: Baseline, Month 1, Month 2, Month 3, and 3-month post-intervention follow-up (Month 6)

06

Study locations

1 site
  • Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Foggia
    Foggia, FG 71122, Italy
07

References and documents

Publications

  • Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2008 Apr 15;23(5):631-40. doi: 10.1002/mds.21922. PubMed 18181210 ↗
  • Rios Romenets S, Anang J, Fereshtehnejad SM, Pelletier A, Postuma R. Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study. Complement Ther Med. 2015 Apr;23(2):175-84. doi: 10.1016/j.ctim.2015.01.015. Epub 2015 Feb 9. PubMed 25847555 ↗
  • Hackney ME, Earhart GM. Effects of dance on balance and gait in severe Parkinson disease: a case study. Disabil Rehabil. 2010;32(8):679-84. doi: 10.3109/09638280903247905. PubMed 20205582 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data collected during the study will be available upon reasonable request to researchers who provide a methodologically sound proposal.

Supporting information: Study protocol, Sap, Icf

08

Registry details

Key details

Study ID
NCT07736014
Lead sponsor
University of Foggia
Responsible party
Anna Antonia Valenzano (Associate Professor, University of Foggia) — Principal investigator
First posted
Jul 30, 2026
Start date
Oct 17, 2024
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Last update
Jul 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion